2012, Number 3
<< Back Next >>
Rev Cub Gen 2012; 6 (3)
Dyggve-Melchior-Clausen syndrome: clinical and radiological findings in three cases from two Pinar del Río families
Menéndez GR, Orraca CM, Juan RJ, Friol SI, Rodríguez RM, Reyes PL
Language: Spanish
References: 11
Page: 48-53
PDF size: 792.24 Kb.
ABSTRACT
The spondylous-epi-metaphyseal dysplasias form a heterogeneous group of disorders comprising more than 20 distinct entities with different inheritance modes; all defined by a combination of vertebral, epiphyseal and metaphyseal abnormalities. These patients generally show a disproportionate low height. Diagnosis is based on skeletal manifestations and the extra-skeletal characteristics that appear along the progression of the disease. The Diggve-Melchior-Clausen syndrome is a spondylous-epi-metaphyseal dysplasia having a rare autosomic recessive form and another one, also recessive, linked to the X chromosome. The first one is due to the loss or mutation affecting the DYM gen function, mapped in 18q12-21.1 that encodes a product of 669 amino acids (Dymeclin) which function was previously unknown. These patients have short torso, low height, and a gaudy “barrel-like thorax” with protruded sternum, kyphoscoliosis, microcephaly and various distal deformities including genu valgum or varum, decreased mobility and a variable degree of mental retardation. Three affected member of two families in the Pinar del Río province are reported.
REFERENCES
Yunis, E. Fontalvo, J., Quintero, L. X-linked Dyggve-Melchior-Clausen syndrome. Clin Genet. 1980;18:284-290. 1.
Osipovich AB2. , Jennings JL, Lin Q, Link AJ, Ruley HE. Dyggve-Melchior-Clausen syndrome: chondrodysplasia resulting from defects in intracellular vesicle traffic. Proc Natl Acad Sci U S A. 2008 Oct 21;105 (42):16171-6.
Dimitrov A3. , Paupe V, Gueudry C, Sibarita JB, Raposo G, Vielemeyer O, Gilbert. The gene responsible for �Dyggve-Melchior-Clausen syndrome encodes a novel peripheral membrane protein dynamically associated with the Golgi apparatus. Hum Mol Genet. 2009 May 1;18(9):1714-6.
Paupe V4. , Gilbert T, Le Merrer M, Munnich A, Cormier-Daire V, El Ghouzzi V. Recent advances in Dyggve-Melchior-Clausen syndrome. Mol Genet Metab. 2004 Sep-Oct;83(1-2):51-9.
Rastogi SC5. , Clausen J, Melchior JC, Dyggve HV, Jensen GE. Lysosomal (leucocyte) proteinase and sulfatasa levels in Dyggve-Melchior-Clausen (DMC) syndrome. Acta Neurol Scand. 1977 Nov;56(5):389-96.
Galasso C6. , Fabbri F, Pagnotta G, Palusci A, Sanna ML, Serrao Arnone D, Scirè G. Dyggve-Melchior-Clausen syndrome: description of 2 further cases. Pediatr Med Chir. 1995 Nov-Dec;17(6):573-6.
Lantigua Cruz Araceli. Introducción a la Genética Médica. Ciudad de la Habana: Editorial Ciencias Médicas, 2004. Cap.18. Prevención de las enfermedades genéticas y Asesoramiento Genético: 251-283.
Dyggve H8. V, Melchior JC, Clausen J, Rastogi SC. The Dyggve-Melchior-Clausen (DMC) syndrome. A 15 year follow-up and a survey of the present clinical and chemical findings. Neuropädiatrie. 1977 Nov;8(4): 429-42.
Coëslier A9. ; Boute-Bénéjean O; Moerman A; Fron D; Manouvrier-Hanu S. Dyggve-Melchior-Clausen syndrome: differential diagnosis of mucopolysaccharidosis type IV or Morquio disease. Arch Pediatr. 2001 Aug;8(8):838-42.
Ehtesham N10. ; Cantor RM; King LM; Reinker K; Evidence that Smith-McCort dysplasia and Dyggve-Melchior-Clausen dysplasia are allelic disorders that result from mutations in a gene on chromosome 18q12. Am J Hum Genet. 2002 Oct;71(4):947-51.
Neumann LM11. ; El Ghouzzi V; Paupe V; Weber HP; Fastnacht E; Leenen A; Lyding S; Klusmann A; Mayatepek E; Pelz J; Cormier-Daire V. Dyggve-Melchior-Clausen syndrome and Smith-McCort dysplasia: clinical and molecular findings in three families supporting genetic heterogeneity in Smith-McCort dysplasia. Am J Med Genet. 2006 Mar 1; 140(5):421-6.